Variable interactions of recipient killer cell immunoglobulin-like receptors with self and allogenic human leukocyte antigen class i ligands may influence the outcome of solid organ transplants

Current Opinion in Organ Transplantation

Volumn 13, Issue 4, 2008, Pages 430-437

  Rajalingam, Raja ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Histocompatibility; Human leukocyte antigen class I specific receptors; Killer cell immunoglobulin like receptors; Natural killer cells; Organ transplantation

Indexed keywords

HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLOGRAFT; ALLOIMMUNITY; ANTIGEN EXPRESSION; CELL FUNCTION; CLINICAL RESEARCH; GRAFT RECIPIENT; HUMAN; IMMUNE RESPONSE; NATURAL KILLER CELL; ORGAN TRANSPLANTATION; PROTEIN INTERACTION; REVIEW;

GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LIGANDS; ORGAN TRANSPLANTATION; RECEPTORS, KIR; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 67649998882     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283095248     Document Type: Review

References (62)

1. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295:2097-2100.
2. Maier S, Tertilt C, Chambron N, et al. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat Med 2001; 7:557-562.
3. Petersson E, Qi Z, Ekberg H, et al. Activation of alloreactive natural killer cells is resistant to cyclosporine. Transplantation 1997; 63:1138-1144.
4. Kageyama S, Matsui S, Hasegawa T, et al. Augmentation of natural killer cell activity induced by cytomegalovirus infection in mice treated with FK506. Acta Virol 1997; 41:215-220.
5. Shapira MY, Hirshfeld E, Weiss L, et al. Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model. Cancer Immunol Immunother 2005; 54:383-388.
6. Pedersen BK, Beyer JM. A longitudinal study of the influence of azathioprine on natural killer cell activity. Allergy 1986; 41:286-289.
7. Luo H, Chen H, Daloze P, Wu J. Effects of rapamycin on human HLA-unrestricted cell killing. Clin Immunol Immunopathol 1992; 65:60-64.
8. BlanchoG, Buzelin F, Dantal J, et al. Evidence that early acute renal failure may be mediated by CD3- CD16+ cells in a kidney graft recipient with large granular lymphocyte proliferation. Transplantation 1992; 53:1242-1247.
9. Petersson E, Ostraat O, Ekberg H, et al. Allogeneic heart transplantation activates alloreactive NK cells. Cell Immunol 1997; 175:25-32.
10. Fildes JE, Yonan N,Tunstall K, et al. Natural killer cells in peripheral blood and lung tissue are associated with chronic rejection after lung transplantation. J Heart Lung Transplant 2008; 27:203-207.
11. Navarro F, Portales P, Candon S, et al. Natural killer cell and alphabeta and gammadelta lymphocyte traffic into the liver graft immediately after liver transplantation. Transplantation 2000; 69:633-639.
12. Lanier LL. On guard-activating NKcell receptors. Nat Immunol 2001; 2:23-27.
13. Ljunggren HG, Karre K. In search of the 'missing self: MHC molecules and NK cell recognition. Immunol Today 1990; 11:237-244.
14. Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23:225-274.
15. McQueen KL, Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr Opin Immunol 2002; 14:615-621.
16. KhakooSI, Rajalingam R, Shum BP, et al. Rapid evolution of NKcell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity 2000; 12:687-698.
17. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002; 20:217-251.
18. Thananchai H, Gillespie G, Martin MP, et al. Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol 2007; 178:33-37.
19. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002; 2:656-663.
20. Faure M, Long EO. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J Immunol 2002; 168:6208-6214.
21. Martin MP, Gao X, Lee JH, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002; 31:429-434.
22. Chewning JH, GudmeCN, Hsu KC, et al. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. J Immunol 2007; 179:854-868.
23. Alter G, Martin MP, Teigen N, et al. Differential natural killer cell mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 2007; 204:3027-3036.
24. Biassoni R, PessinoA, Malaspina A, et al. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol 1997; 27:3095-3099.
25. Stewart CA, Laugier-Anfossi F, Vely F, et al. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci USA 2005; 102:13224-13229.
26. Arase H, Mocarski ES, Campbell AE, et al. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002; 296: 1323-1326.
27. Valiante NM, Uhrberg M, Shilling HG, et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997; 7:739-751.
28. Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001; 19:291 -330.
29. Anfossi N, Andre P, Guia S, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006; 25:331 -342.
30. Kim S, Poursine-Laurent J, Truscott SM, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005; 436:709-713.
31. Cooley S, Xiao F, Pitt M, et al. Asubpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self MHC is developmentally immature. Blood 2007; 110:578-586.
32. Bix M, Liao NS, Zijlstra M, et al. Rejection of class I MHC-deficient haemo-poietic cells by irradiated MHC-matched mice. Nature 1991; 349:329-331.
33. Furukawa H, YabeT, Watanabe K, et al. Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I). Hum Immunol 1999; 60:32-40.
34. Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol 2006; 6:520-531.
35. Du Z, Gjertson DW, Reed EF, Rajalingam R. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics 2007; 59:1-15.
36. Yu J, Heller G, Chewning J, et al. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J Immunol 2007; 179:5977-5989.
37. Wilson MJ, Torkar M, Haude A, et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA 2000; 97:4778-4783.
38. Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity 2001; 15:363-374.
39. Martin MP, Bashirova A, Traherne J, et al. Cutting edge: expansion of the KIR locus by unequal crossing over. J Immunol 2003; 171:2192-2195.
40. Maxwell LD, Wallace A, Middleton D, Curran MD. A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous totheKIR1D molecule observed in the rhesus monkey. Tissue Antigens 2002; 60:254-258.
41. Yawata M, Yawata N, Abi-Rached L, Parham P. Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family. Crit Rev Immunol 2002; 22:463-482.
42. Rajalingam R, Du Z, Meenagh A, et al. Distinct diversity of KIR genes in three southern Indian populations: comparison with world populations revealed a link between KIR gene content and prehistoric human migrations. Immunogenetics 2008; 60:207-217.
43. Shilling HG, Guethlein LA, Cheng NW, et al. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol 2002; 168:2307-2315.
44. Yawata M, Yawata N, Draghi M, et al. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 2006; 203:633-645.
45. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47:187-376.
46. Martin-Fontecha A, Thomsen LL, Brett S, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004; 5:1 260-1265.
47. Wang H, Ruan Z, Wang Y, et al. MHCclass I chain-related molecules induced on monocytes by IFN-gamma promote NK cell activation. Mol Immunol 2008; 45:1548-1556.
48. Rouas-Freiss N, Goncalves RM, Menier C, et al. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 1997; 94:11520-11525.
49. Crispim JC, Duarte RA, Soares CP, et al. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection. Transpl Immunol 2008; 18:361-367.
50. Creput C, Durrbach A, Menier C, et al. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 2003; 39:587-594.
51. Lila N, Carpentier A, Amrein C, et al. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000; 355:2138.
52. LeRond S, Azema C,Krawice-Radanne I,et al. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells. J Immunol 2006; 176:3266-3276.
53. Joosten SA, van Kooten C, Paul LC. Pathogenesis of chronic allograft rejection. Transpl Int 2003; 16:137-145.
54. Yu G, Xu X, Vu MD, et al. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006; 203:1851-1858.
55. Gao B, Jeong WI, Tian Z. Liver: an organ with predominant innate immunity. Hepatology 2008; 47:729-736.
56. Hahn AB, Baliga P. Rapid method for the analysis of peripheral chimerism in suspected graft-versus-host disease after liver transplantation. Liver Transpl 2000; 6:180-184.
57. Mingari MC, Schiavetti F, Ponte M, et al. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci U S A 1996; 93:12433-12438.
58. Ugolini S, Arpin C, Anfossi N, et al. Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells. Nat Immunol 2001; 2:430-435.
59. TranTH, Mytilineos J, SchererS, et al. Analysis of KIR ligand incompatibility in human renal transplantation. Transplantation 2005; 80:1121-1123.
60. Kunert K, Seiler M, Mashreghi MF, et al. KIR/HLA ligand incompatibility in kidney transplantation. Transplantation 2007; 84:1527-1533.
61. Vampa ML, Norman PJ, Burnapp L, et al. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch. Transplantation 2003; 76:1220-1228.
62. Bishara A, Brautbar C, Zamir G, et al. Impact of HLA-C and Bw epitopes disparity on liver transplantation outcome. Hum Immunol 2005; 66:1099-1105.